Skip to main content

Table 3 Butyrylcholinesterase inhibition of compounds 1-4

From: Synthesis, anticholinesterase and antioxidant potentials of ketoesters derivatives of succinimides: a possible role in the management of Alzheimer’s

Compounds

Concentration

Percent AChEI

IC50

 

(μg/mL)

(mean ± SEM)

(μg/mL)

1

1000

90.25 ± 0.02 ns

42

 

500

82.50 ± 0.18 ns

 
 

250

72.50 ± 0.02 ns

 

2

1000

90.00 ± 0.10 ns

<0.1

 

500

86.75 ± 0.22 ns

 
 

250

84.25 ± 0.12 ns

 

3

1000

89.25 ± 0.50 ns

7

 

500

89.00 ± 0.30 ns

 
 

250

78.25 ± 0.04 ns

 

4

1000

98.50 ± 0.18 ns

2

 

500

88.50 ± 0.50 ns

 
 

250

87.50 ± 0.04 ns

 

Galanthamin

1000

94.50 ± 0.71

53

e

500

85.47 ± 0.59

 
 

250

71.72 ± 0.51

 
  1. Data is represented as mean ± SEM, n = 3
  2. Two-way ANOVA followed by Bonferroni test was applied for significant difference between standard drugs and test samples at 95 % confidence interval. Values significantly not different in comparison to standard drug